Localization of cyclic AMP (cAMP)-dependent protein kinase (PKA) by A kinase-anchoring proteins (AKAPs) restricts the action of this broad specificity kinase. The high-resolution crystal structures of the docking and dimerization (D/D) domain of the RIIa regulatory subunit of PKA both in the apo state and in complex with the high-affinity anchoring peptide AKAP-IS explain the molecular basis for AKAP-regulatory subunit recognition. AKAP-IS folds into an amphipathic a helix that engages an essentially preformed shallow groove on the surface of the RII dimer D/D domains. Conserved AKAP aliphatic residues dominate interactions to RII at the predominantly hydrophobic interface, whereas polar residues are important in conferring R subunit isoform specificity. Using a peptide screening approach, we have developed SuperAKAP-IS, a peptide that is 10,000-fold more selective for the RII isoform relative to RI and can be used to assess the impact of PKA isoform-selective anchoring on cAMPresponsive events inside cells.
Introduction cAMP-dependent protein kinase (PKA) has served as a paradigm in several biological contexts. It first came to prominence 50 years ago as the predominant intracellular receptor for cAMP, acting downstream of G protein-coupled receptors via the activation of adenylyl cyclase. The resulting PKA phosphorylation events exert diverse biological effects by changing the activity of a range of protein substrates (Shabb, 2001) . The broad-substrate specificity of PKA is directed toward specific intracellular substrates by a multigene family of AKAPs. AKAPs serve to target PKA to distinct subcellular loci and coordinate multiple signaling enzymes in supramolecular complexes. This scaffolding function permits optimal spatiotemporal resolution and integration of signal transduction pathways (Wong and Scott, 2004) . Characterization of these complexes is critical to understand signaling pathway integration (Pawson and Scott, 1997; Smith et al., 2006) .
The PKA holoenzyme is a tetramer of two catalytic subunits (C) that are maintained in an inactive conformation by a regulatory (R) subunit dimer. R subunit association with cAMP releases the active C subunits to permit phosphorylation in the local vicinity (reviewed in Wong and Scott [2004] ). Through its N-terminal D/D domain, the R subunit dimer of PKA associates with an amphipathic helix of 14-18 residues common to all AKAPs (Carr et al., 1991) . Since the identification of the first AKAP (Lohmann et al., 1984; Vallee et al., 1981) , over 50 members of the family are now known, with roles in the modulation of ion channels (Johnson et al., 1994; Rosenmund et al., 1994; Westphal et al., 1999) , insulin secretion (Alto et al., 2002; Zhang et al., 2005) , cardiac function (Fink et al., 2001) , auditory fear (Moita et al., 2002) , and lipoprotein lipase translation (Ranganathan et al., 2005) . The potential for multivalency in AKAPs, first demonstrated for AKAP79 (Klauck et al., 1996) , is now recognized as a common mechanism to mediate signal integration. Variations on this theme are exemplified by mAKAP (Dodge-Kafka et al., 2005) and AKAPLbc (Carnegie et al., 2004) . Importantly, AKAPs are also responsible for differential targeting of the two R subunit isoforms, conferred by RI, RII, or dual-specificity AKAPs (Angelo and Rubin, 1998; Huang et al., 1997; Li et al., 2001 ). R type specificities of different AKAPs have also been characterized in vitro (Herberg et al., 2000) , and the only disease-related SNP identified in an AKAP to date alters R subunit specificity .
The structural basis for the AKAP-D/D interaction has been studied by NMR for the RIIa D/D domain (Newlon et al., 2001 ) and more recently modeled by using an NMR structure of the RIa D/D domain (Banky et al., 2003) . The general binding mode is established for RIIa, with the AKAP helix binding diagonally to a hydrophobic surface of a four-helix bundle formed by the two RII D/D domains. However, information regarding sitespecific intermolecular amino acid contacts, crucial for defining R subunit specificity, remains to be established.
Several studies aimed at identifying the sequence determinants for AKAP binding have established the crucial role of hydrophobic residues on one face of the helix (Miki and Eddy, 1999) . In RIIa, residues Ile3 R and Ile5 R (superscript ''R'' denotes residues of RIIa) have been proposed as key binding determinates (Hausken et al., 1996) , and peptide substitution arrays have been used to derive high-affinity AKAP peptides (Alto et al., 2003; Burns-Hamuro et al., 2003) . In a previous study, Alto and colleagues employed bioinformatic and peptidearray screening approaches to generate a reagent, AKAP-IS, which binds RIIa with a K d of 0.4 nM, an affinity some 5-fold higher than for the AKAP-Lbc derived peptide Ht31 (Alto et al., 2003) . Here, we describe the crystal structure of the D/D domain of RIIa in complex with an AKAP (AKAP-IS), providing a molecular explanation of AKAP and RIIa-subunit sequence recognition determinants and a framework for rationalizing the results of peptide-array screening data. Although AKAP-IS binds well to RIIa and has some affinity for RIa, we have now explored specificity of the R subunit-AKAP interaction and have developed an improved reagent, SuperAKAP-IS, through a peptide screening approach. SuperAKAP-IS has some 4-fold higher affinity for RIIa and 12.5-fold reduced affinity for RIa compared to AKAP-IS, as judged by peptide screening. The peptide-array screening data and crystal structure provide insight at the molecular level into the determinants of high-affinity binding to RII and for R subunit selectivity.
Results
The Apo RIIa D/D Dimer Forms an X Type Four a Helix Bundle We first determined the crystal structure of the apo RIIa D/D dimer (residues Ser1 R -Arg43 R [symmetry-related protomer is denoted ''R prime'']) to 2.2 Å resolution (Table 1) . Two RIIa D/D domains dimerize to form an X type four-helix bundle, with an antiparallel arrangement of the two RIIa D/D domain a helices (denoted A and B) ( Figure 1A ). Four independent RIIa D/D dimers generated from eight individual protomers comprise the crystal asymmetric unit. As judged from pair-wise structural comparisons, the protomers adopt essentially identical conformations, with an average root-meansquare deviation (rmsd) between equivalent Ca atoms of 0.2 Å , with only small differences in the conformation of solvent-exposed Arg side chains (Table S1 in the Supplemental Data available with this article online) (Figure 1C) . For all molecules, the two N-terminal residues (Ser1 R and His2 R ) are disordered. Electron density corresponding to the main chain of Ile3 R is visible in five molecules, although its side chain is ordered in only three of these. For three other protomers, the polypeptide chain become structured at Gln4 R ( Figure 1C and Table S1 ). The N-terminal three residues of RIIa D/D therefore represent a relatively mobile region of the RIIa D/D subunit, with the conformation of Ile3 R restrained by AKAP interactions (see below).
AKAP-IS Engages a Shallow Hydrophobic Groove on RII D/D
We determined the AKAP-IS-RIIa D/D complex to 1.3 Å resolution (Table 1 ) ( Figure 1B) . The 18 residues of AKAP-IS (Gln4-Lys21) ( Figure 2A ) are well resolved in electron density, except for the side chain of Gln4. AKAP-IS forms five turns of an amphipathic a helix, lying diagonally (w50 ) across one face of the symmetrical RII dimer of the N-terminal helices (A and A 0 ) of each RIIa subunit ( Figure 1B ). Due to crystal contacts, an asymmetric orientation of the RIIa-AKAP-IS complex is generated whereby AKAP-IS adopts a unique polarity across the RII-subunit AKAP interface. Interestingly, the symmetry of the AKAP-interaction interface within the RII D/D homodimer is reflected in a pseudo 2-fold symmetry of the AKAP-IS primary structure centered on residues Asp14 and Asn15 (Figures 2A and 2B ). These two residues define the position within AKAP-IS that bisects the RII D/D dyad axis within the RII-AKAP-IS complex ( Figure 2B ). A symmetrical pattern of hydrophobic and hydrophilic amino acids is centered on these two residues, illustrating how an asymmetric a helix interacts with a symmetrical interface. However, notable asymmetry is introduced into the RIIa-AKAP-IS complex by the ordering of two additional residues (Ile3 R 0 and Gln4 R 0 ) at the N terminus of aA 0 relative to aA of RII, promoted by its interactions with Ile5 and Leu8 of AKAP-IS (Figures 1C, 2C , and 4). In the opposite protomer, Ile5
R is the first ordered N-terminal residue. Overall, the two RII D/D protomers of the RII-AKAP-IS complex are very similar; equivalent Ca atoms superimpose within 0.5 Å , essentially identical to their individual differences with the apo RII D/D structure (Table S1 and Figure 1C ). Moreover, the relative orientations of RII D/D protomers within the dimer are similar in the apo and complex structure (rmsd between equivalent Ca atoms of 0.6 Å ), suggesting that, apart from the N-terminal two residues of one RII D/D protomer, the tertiary and quaternary conformations of RII D/D do not change on association with AKAP-IS. A prominent AKAP binding channel on RIIa measuring 8 by 30 Å accommodates the amphipathic AKAP-IS a helix ( Figures 3A and 3D ). Residues Ile5-Lys21 of AKAP-IS interact with RIIa (defined at interatom distances <4 Å ). Notably, two AKAP-IS residues, Ile5 and Ala20, define the critical N-and C-terminal anchor points Four short-chain nonpolar aliphatic residues of AKAP-IS (Ala9, Val13, Ala16, and Ala20) project toward the center of the hydrophobic face presented by RIIa and are completely buried at the interface. In contrast, longer aliphatic residues (Ile5, Leu8, Ile12, and Ile17) project from the sides of the helix and are partially solvent exposed ( Figure 3 ). Together, these residues create a hydrophobic ridge running along the AKAP helix axis, forming intimate associations with the predominantly hydrophobic surface of the RII AKAP interface ( Figure 3A ). The nonpolar-AKAP interface of RIIa is formed from the side chains of tightly interpacked aliphatic residues; bulky aromatic residues do not participate ( Figure 3B ). Thus, a rigid, relatively featureless shallow surface is created, lacking distinct cavities or protrusions, complementary to the uniform hydrophobic surface of AKAP-IS ( Figures  3B and 3D ). Water molecules are excluded from the RII-AKAP interface, whereas Thr17 R and Thr17 R 0 in RIIa are the only polar-buried residues. The interactions between residues Ile5 and Leu8 of AKAP-IS and Ile3 R 0 and Ile5 R 0 in aA 0 are notable (Figures 2C and 4A): Ile3 R 0 and Ile5 R 0 had previously been proposed as essential components of the RIIa interface, and the absence of Pro7 R 0 in RIIb was suggested as a means to distinguish between the two RII isoforms (Hausken et al., 1994) , potentially accounting for the 4-fold weaker affinity for the b isoform displayed by D-AKAP2 . Hydrogen/ deuterium exchange data, which showed free exchange of these isoleucines in complex with AKAP peptides , apparently in conflict with our structure, are in fact due to the asymmetric binding of AKAP to the RII interface, leaving one N terminus of RII solventexposed ( Figures 2D and 4) . Other Sequence-Dependent RII-AKAP Interactions A striking feature of the structure is that the RII residue pairs [Thr10 2D and 4B), and Gln19 of AKAP-IS is H bonded to Gln14 R 0 ( Figures 2D and 4A ). The side chain of Thr10 R 0 , which lacks the potential to H bond with Asp14 of AKAP-IS, instead forms a water-mediated contact to Asn15 ( Figures 2D and 4A ). Helix-Stabilizing Interactions within AKAP-IS Helix-stabilizing interactions within the AKAP helix had previously been suggested as a mechanism to increase affinity (Alto et al., 2003) . In our structure, we note three interactions within AKAP-IS that are likely to stabilize the helix. Between adjacent turns there is a stacking interaction between Tyr7 and Gln11 and an H bond between Asn15 and Gln19 ( Figure 4A ). Gln19 therefore participates in a network of H bonds involving Asn15 and, as noted above, Thr10 R 0 and Gln14 R 0 of RII ( Figure 4A ). Significantly, RII-peptide array analysis revealed that an Asn is preferred at position 15 in the AKAP helix (Alto et al., 2003) , and Asn and Gln at positions 15 and 19, respectively, are conserved within RII-specific AKAPs (Figure 2A ). In addition, the side chain of Glu6 folds back to satisfy an H bond to its backbone amino group in a classical helix-capping interaction ( Figure 4B ). Interestingly, previous reports had predicted that Glu6 would form an intrahelix salt bridge with Lys10, accounting for its ability to stabilize AKAP-RII interactions (Alto et al., 2003) , whereas we find that the two charged side chains are positioned some 10 Å apart. The side chain of Glu6 also forms a long salt bridge with the guanidinium side chain of Arg22 R ( Figure 4B ). In the RIIa-AKAP-IS complex, Lys10 is exposed to solvent, and the ability of a lysine at this position to optimize interactions with RII is not readily apparent.
Comparison to Other R Subunit D/D Structures
Apo RIIa Crystal Structure A comparison of the RII-AKAP-IS complex with the 2.2 Å resolution crystal structure of apo RIIa reveals that RII presents a predominantly rigid docking surface for the engagement of AKAPs. The two RII D/D structures are essentially identical, superimposing within an rmsd of 0.6 Å for equivalent Ca atoms (Table S1 ). Significantly, side chain conformations of residues forming the AKAP binding surface vary little between the two structures: the hydrophobic residues at positions 9, 13, 18, 20, and 21 superimpose with an rmsd of 0.6 Å for all atoms. The N-terminal region containing residues Ile3 R 0 -Ile5 R 0 in protomer 2 represents the largest difference between the apo and complex conformations of RII D/D ( Figures 1C and 4) . In the RII-AKAP-IS structure, Ile3 R 0 and Gln4 R 0 of protomer 2 are well defined but disordered in protomer 1. Compared to their conformations in the apo structure, residues Ile3 R 0 -Ile5 R 0 shift by 2-3 Å in the complex to avoid steric clashes with Ile5, Leu8, and Ile12 of AKAP-IS ( Figures 1C and 4) . The conformation of Ile5 R in protomer 1 in the RII-AKAP-IS complex is essentially unchanged relative to the apo structures ( Figure 1C) . Notably, the N-terminal residues of protomer 2 (Ile3 R 0 -Ile5 R 0 ) that shift position on forming the complex contribute only 9% of the total buried area at the RII D/D-AKAP-IS interface. Outside of the core hydrophobic interface, alternative rotamer conformations are observed for the side chains of Thr10 R , Gln14
R 0 , and Arg22 R , all of which contact AKAP-IS (Figure 4 ). NMR RIIa-Ht31 Structure The NMR structure of RIIa-Ht31 differs from our structure in a number of respects. The RII D/D dimers superimpose with an rmsd of 1.4 Å for equivalent Ca-atoms, with the largest differences occurring at the two N termini ( Figure 5A ). In the NMR structure, the AKAP peptide Ht31 binds w25 more parallel to the N-terminal RII helices than AKAP-IS. The two AKAP peptides are very similar (Figure 2A , Ht31 represents the RII binding sequence in the multifunctional anchoring protein AKAPLbc) and would be expected to share the same binding mode. In the NMR structure, the critical Ile3 R residues at the two N termini of the RII dimer face away from Ht31 into solution. As previously noted by the authors, this is likely to be an artifact arising from the presence of a partial His tag at each N terminus that is expected to be protonated at the low pH (pH 4) of the NMR experiment (Newlon et al., 2001) . Furthermore, accurately positioning the AKAP helix by NMR is challenging due to the 2-fold symmetry of the RII interface. RIa D/D Apo NMR Structure Core residues in the two D/D subunits (residues 9 R -43 R in RIIa) align with an rmsd of 1.8 Å for equivalent Ca atoms, unusually high considering the 29% sequence identity between the two human R subunits ( Figure 5B ). The isoform-specific docking region of RIa (Banky et al., 2003) is similarly positioned to the Ile3 , such that 17 equivalent Ca atoms superimpose with an rmsd of 1.5 Å .
Optimization of AKAP-IS to Yield an RIIa-Specific Peptide In order to learn more about the specificity of R subunit-AKAP interactions, we used AKAP-IS that binds both RII and RI with low and high nanomolar affinity, respectively (Alto et al., 2003) , as a starting point for further rounds of two-dimensional peptide array screening to find specific determinants for AKAP interaction with RIIa and RIa. The goal of these studies was to develop an RII-specific anchoring disruptor. Analysis of 340 AKAP-IS peptide derivatives where each residue in AKAP-IS (given by its single-letter code above each array) was replaced by all 20 amino acids (given by their single-letter codes to the left of each array) was conducted by overlay assays (Figure 6 ). R binding was analyzed by RIIa-32 P ( Figure 6A ) or RIa-32 P overlay ( Figure 6B ) and detected by autoradiography. The apparent binding affinity of each modified peptide was compared with the signal strength of internal control peptides (AKAP-IS) in the upper row and distributed throughout the array (white circles). The preferred positions of the substitutions were 8, 11, 15, 16, 18, 19, and 20 (marked with red circles). Interestingly, L8H, L8K, or L8V substitution decreased RIa binding dramatically, whereas apparent RIIa affinity was increased. Fifteen peptides with lower affinity for RIa and higher affinity for RIIa (out of 40 modified peptide derivatives with single, double, and triple substitutions tested) are shown in Figure 6C . The relative RIIa and RIa binding was measured by densitometry analysis of the autoradiographs (n = 3). In the filter assays, the peptide with the triple substitutions L8V, N15Y, and Q18H (denoted with a star in Figure 6C ) had a four times higher apparent affinity for RIIa compared to that of AKAP-IS. This peptide, named SuperAKAP-IS (QIEYVAKQIVD YAIHQA), exhibited the most RII-selective profile. The SuperAKAP-IS peptide exhibited a 12.5 times lower apparent affinity for RIa but retained its high affinity for RII.
SuperAKAP-IS Is Selective for RII SuperAKAP-IS was cloned with preferred codon usage and fused to the C terminus of GFP. Lysates from HEK293 cells transfected with GFP, GFP-AKAP-IS, GFP-SuperAKAP-IS, and GFP-scrambledAKAP-IS were separated by PAGE and R binding analyzed by RIa-32 P and RIIa-32 P overlay ( Figure 7A , middle and top panels, respectively). Whereas AKAP-IS had some affinity for RIa (lane 2), RIa binding was abolished for SuperAKAP-IS (lane 4). AKAP-IS and SuperAKAP-IS appeared to bind with similar strength to RIIa in the R overlay (lane 2 and 4, respectively).
Next, the characteristics of SuperAKAP-IS as a competitor were analyzed by adding peptide (1 mM) to RIIa-32 P in solution before an overlay experiment was performed ( Figure 7B ). SuperAKAP-IS in solution competed most of the RIIa-32 P binding to SuperAKAP-IS synthesized on membrane in concentrations of 0.5 (data not shown) to 1 mM ( Figure 7B ). SuperAKAP-IS synthesized on membrane also bound human RIIa with a similar affinity as for mouse RIIa, indicating that this peptide should be able to compete and displace RIIa-AKAP interactions in situ both in human and rodent cells (data not shown). In contrast to AKAP-IS, SuperAKAP-IS revealed no binding to human RIa (data not shown).
Having established that SuperAKAP-IS binds specifically to RIIa and not to RIa in vitro, it was important to test whether this peptide could selectively disrupt type II PKA anchoring inside cells. A cell-permeable SuperA-KAP-IS derivative was generated by coupling 11 arginine residues to the N terminus of the peptide (Arg 11 -SuperAKAP-IS). Previous studies have shown that the addition of a polybasic sequence renders the peptide derivatives cell soluble. The PKA anchoring disruptor properties of Arg 11 -SuperAKAP-IS were compared to arginine-coupled derivatives of AKAP-IS, Ht31, and a recently described RI-selective anchoring disruptor peptide called RIAD (Carlson et al., 2006) (Figure 7C ). Application of Arg 11 -SuperAKAP-IS displaced PKA-RIIa from the cell membrane of human T cells at concentrations of 25-50 mM as demonstrated by immunofluorescence ( Figure 7C , top two rows) when compared to untreated cells ( Figure 7C , left column). In contrast, no displacement of PKA-RIa was observed in cells treated with Arg 11 -SuperAKAP-IS ( Figure 7C , bottom row). Conversely, the RI-selective competitor peptide RIAD displaced RIa, but not RIIa as assessed by the immunofluoresence assay. As anticipated, AKAP-IS and Ht31 disrupted RI and RII anchoring in these cells ( Figure 7C , middle panels).
Although our immunofluorescence study did not appear to detect any significant differences in the potency of SuperAKAP-IS and AKAP-IS as competitors of RII anchoring, we were able to conclude that Arg 11 -SuperA-KAP-IS is a potent and selective RII anchoring disruptor peptide. This latter observation is supported by evidence that both peptides display subnanomolar affinities for RIIa when assessed by in-solution fluorescence polarization (data not shown). Nonetheless, SuperA-KAP-IS is the most selective RII-directed anchoring disruptor reagent developed to date and can be used as a tool to delineate cellular effects mediated by anchored pools of type II PKA holoenzyme.
We next attempted to uncouple anchored signaling events that are attributed to the PKA type II holoenzyme. A physiologically relevant model is the time-dependent downregulation (run down) of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-responsive currents in hippocampal neurons after addition of glutamate. This requires an anchored pool of type II PKA as demonstrated by anchoring disruption using the Ht31 anchoring disruption peptide (Rosenmund et al., 1994) . by densitometry analysis of the autoradiographs (means 6 STD from n = 3). Binding of RIIa and RIa to AKAP-IS was arbitrarily set to one for this comparison. Note that affinity of AKAP-IS to RIIa and RIa differs (Alto et al., 2003) . Star denotes peptide selected for further characterization (named SuperAKAP-IS).
Whole-cell patch-clamp techniques provided a sensitive means to record the current upon delivery of the different bioactive peptides through the patch pipette. Perfusion of SuperAKAP-IS (1 mM) caused rapid reduction in the AMPA-responsive currents to a similar extent as PKI (PKA inhibitor) included as control, indicating the ability of SuperAKAP-IS to interfere with PKA type IImediated regulation of ion-channel conductivity (Figure 7D) . Additional control experiments demonstrated that scrambled peptide (scSuperAKAP-IS, negative control) was unable to affect AMPA-responsive currents ( Figure 6D ). Thus, SuperAKAP-IS appears to be able to Lysates from HEK293 cells transfected with GFP, GFP-AKAP-IS, GFP-scAKAP-IS, and GFP-SuperAKAP-IS were analyzed for R binding by RIIa-32 P or RIa-32 P overlay. Immunoblotting using GFP antibody was used as loading control (bottom). (B) SuperAKAP-IS and its scrambled peptide were synthesized on membranes. RII binding was detected by RIIa-32 P overlay in absence (top row) or presence of 1 mM SuperAKAP-IS peptide in the solution. (C) Subcellular localization of PKA-RIIa (top two rows) and PKA-RIa (bottom row) in human peripheral blood T cells that received no peptide (left) or were treated (right) with 25 mM (top row) or 50 mM (two bottom rows) Arg 11 -coupled competitor peptides RIAD, SuperAKAP-IS, AKAP-IS, or Ht31 and analyzed by immunofluorescence. (D) The effect of SuperAKAP-IS on time-dependent run down of AMPA-responsive currents in hippocampal neurons was analyzed by using whole-cell patch-clamp recording techniques (left). PKI (PKA inhibitor) was used as a positive control, and the scrambled control peptide scSuperAKAP-IS was used as negative control. Averaged peak currents from 0 to 10 min are shown. Graphical representation of the peak current amplitudes upon glutamate stimulation 5 min after delivery of the peptides (indicated below each column, right). Each bar is normalized to the peak amplitude found at time 0. PKI was used at 10 mM, and other peptides were used at a concentration of 1 mM (means 6 SEM from n = 4-11).
specifically block cellular functions mediated by the type II PKA holoenzyme.
Discussion
The RIIa-AKAP-IS complex structure described here provides a molecular framework for understanding the specificity determinants for RII, RI, and dual-selective AKAPs. This study also provides a compelling rationalization for the results of peptide array AKAP-RII and RI interaction screens. All AKAPs feature nonpolar residues at positions 5, 9, 12, 13, 16, 17, and 20 (Figure 2A) , which in our structure form a hydrophobic ridge for docking onto the nonpolar RII-AKAP binding interface ( Figure 3A) . Strikingly, RII-peptide array screening data indicated that high-affinity AKAP-RII interactions are not compatible with bulky residues at these positions (this study; Burns-Hamuro et al., 2003; Alto et al., 2003) , consistent with the intimate contacts between AKAP-IS and RIIa. Interestingly, the RII-peptide array screen revealed that the affinity of RII-AKAP interactions was particularly sensitive to substitutions of AKAP residues at positions 9, 13, and 16 (this study and Alto et al. [2003] ). At positions 9 and 16, an Ala is preferred and only the small Gly, Thr, and Ser residues are tolerated. A Val is strongly preferred at position 13, with Ala, Ile, Thr, and Cys being weakly tolerated (Alto et al., 2003) (Figure 6A ). In the structure, Ala9, Val13, and Ala16 are deeply buried at the RII-AKAP interface, suggesting that residues larger than Ala or Val at these positions could not be readily accommodated. Ala9, Val13, and Ala16 are highly conserved in RII-specific AKAPs (Figure 2A) .
Ile17 is more solvent exposed, explaining the greater variability of residues tolerated at this position. BurnsHamuro and colleagues discovered that while a Trp at position 17 was compatible with RI binding, RII binding was eliminated . Ile17 engages a hydrophobic pocket defined by Ile5 R and Leu9 R in RIIa ( Figure 4B ). The equivalent residues in RIa are Gln and Ile, suggesting that in RI there exists a larger more-hydrophilic pocket capable of accommodating the large and partially polar Trp side chain.
Our structure also provides insights into how the three mutants of AKAP-IS generate the more affine RII binding SuperAKAP-IS while abolishing its affinity for RI. The Leu8Val mutation led to a large drop in binding affinity for RIa but had little effect on RIIa binding. This finding suggested that in RIIa the loop containing Ile3 R 0 and Ile5 R 0 can reorganize to accommodate Val8. Despite low sequence identity between the RII and RI D/D domains, the N-terminal loop of aA 0 is positioned similarly to the helical isoform-specific docking region proposed in the RI NMR structure (Banky et al., 2003) . Peptide screening showed that RI binding was enhanced by larger nonpolar residues such as Phe and Tyr ( Figure 5B and Burns-Hamuro et al. [2003] ). This suggests that a substitution of Val for Leu at position 8 results in the loss of high-affinity nonpolar packing interactions between AKAP and RI.
The Asn15Tyr and Gln18His mutations led to an increase in affinity for RIIa, despite the crystal structure indicating that the Asn15Tyr substitution would break an intrahelical H bond. This may be compensated for by the formation of a direct H bond from Tyr15 to Thr10 R 0 in RIIa or by the formation of an intrahelical stacking interaction between Tyr15 and His18. His18 is suitably placed to cap the helix at the C terminus; however, the crystal structure is not informative in this respect, as an additional lysine has been included at the C terminus to improve solubility of the peptide for crystallization.
The AKAP-IS interactions to Thr10 R and Gln14 R at the corners of the RIIa interface add an intriguing extra level of subtlety to the RII interface ( Figure 2D ). For RI, the equivalent pairs are Gly and Lys, respectively. Alignment of dual, RII-and RI-specific AKAP peptides (Figure 2A ) reveals striking differences in AKAP positions 15 and 19 that contact these residues. Acidic residues predominate at position 19 of dual and RI-specific AKAPs (Figure 2A ), and these in principle could salt bridge to Lys14R of RI (equivalent to Gln14 R of RII). In RII-specific AKAPs, Asn15 and Gln19 are favored, which we observe to H bond to Thr10 R 0 and Gln14 R 0 in RII ( Figure 2D ). This suggests a mechanism by which polar interactions outside of the hydrophobic core distinguish between the RI and RII isoforms.
In general, AKAP proteins bind more tightly to RII than RI. Although RI-selective peptides have been engineered Carlson et al., 2006) , the only naturally occurring RI-selective AKAP that has been conclusively shown to have a poor K d for RII is AKAPce (Angelo and Rubin, 1998) . However, this may be the exception rather than the rule, as there is only one R subunit isoform in C. elegans, which is marginally more similar to RI than RII. Both the Ile3 R 0 /Ile5 R 0 loop and Thr10 R -Gln14 R pairs in RIIa are compatible with a range of substitutions in the appropriate positions in AKAP ( Figure 2C ), whereas peptide screening indicates that RI is less accommodating in the equivalent positions . This correlates with the ability of RII to bind to a broad range of AKAPs with high affinity.
RI and RII differ physiologically in both their localization (Skalhegg and Tasken, 2000) and cAMP responsiveness (Feliciello et al., 2001) . In tandem with RI-specific AKAP peptides such as RIAD (Carlson et al., 2006) , SuperAKAP-IS will, with its demonstrated specificity for RII, be a useful in vivo reagent for assessing the contribution of anchoring of the different R subunit isoforms in various cellular processes. Further structural studies of D/D complexes will clarify the mechanisms that determine AKAP affinity and specificity. These may include sp17, a non-PKA D/D domain shown to bind AKAPs (Frayne and Hall, 2002) , and Rfc40, reported to bind the D/D domain of RI (Gupte et al., 2005) .
Experimental Procedures Protein Expression and Purification
Murine RIIa (1 R -43 R ) was cloned into pET30 incorporating a C-terminal RGLEH 6 sequence. The protein was purified by Ni-NTA and Superdex 75 chromatography. Human RIIa (1 R -45 R ) was cloned into pGEX6P3 and expressed as GST-fusion protein (Amersham Biosciences). The protein was purified by using glutathione Sepharose (Amersham Biosciences), and bound protein was cleaved from the beads overnight with PreScission (Amersham Biosciences) and finally purified by size-exclusion chromatography on Superdex 75 in 15 mM Tris-HCl (pH 7.5), 200 mM NaCl, 0.5 mM EDTA, and 2 mM DTT. For noncrystallographic work, bovine, murine, or human R protein was expressed in E. coli BL21 by IPTG induction and purified with cAMP beads.
Protein Crystallization
Apo RIIa was crystallized by vapor diffusion with 8%-10% PEG 400, 0.2-0.4 M sodium phosphate, and sodium citrate (pH 5.8), and crystals were flash-frozen with cryo-protection buffer consisting of 20% mother liquor and 80% saturated lithium acetate. Crystals of the RIIa (1 R -45 R )-AKAP-IS (sequence: QIEYLAKQIVDNAIQQAK) complex were initially obtained by hanging drop vapor diffusion by selecting for crystals that only appeared when the AKAP-IS peptide was present. The best diffracting crystals were grown at 4 C in 1 M trisodium citrate, 0.1 M Tris-HCl (pH 7.5), with RII:AKAP in a 4:3 molar ratio and RIIa (1 R -45 R ) at 15 mg/ml. For cryoprotection, crystals were immersed for 2 min in 1 M trisodium citrate, 150 mM NaCl, 0.1 M Tris-HCl (pH 7.5), and 25% glycerol.
Data Collection and Structure Determination
Apo RIIa (1 R -43 R ) To determine the crystal structure, we substituted Met individually for each of the three Leu residues (Leu 9 R , 12 R , and 28 R ). The structure was solved with MAD data by means of SHELXS and SOLVE software and refined by using CNS. These refined coordinates were used to determine the native wild-type RII D/D crystal structure and refined to 2.2 Å with REFMAC (Table 1) . NCS restraints were applied during initial refinement stages but removed during the final stages of refinement. The regions of RII D/D that are visible in the electron density map are listed in Table S1 .
R )-AKAP-IS Data were processed by using MOSFLM and scaled and merged in SCALA (CCP4, 1994). The structure was solved by molecular replacement with PHASER (McCoy et al., 2005) using apo RII as the search model. The AKAP-IS peptide and additional residues were manually built by using COOT, and the complex structure was refined in REFMAC5 with anisotropic B factors ( Table 1) . The model includes two DTT molecules, assigned by apparent electron density. All molecular representations in figures were created by using the PyMOL Molecular Graphics System (DeLano Scientific, http:// www.pymol.org).
Autospot Peptide Array
Peptide arrays were synthesized on cellulose paper by using an Autospot Robot ASP222 or a Multipep automated peptide synthesizer (INTAVIS Bioanalytical Instruments AG) as described (Frank, 2002) .
Densitometric Analysis
The densitometric analysis was performed with Scion Image (Scion Coorperation, http://www.scioncorp.com) or Quantity One version 4.5.0 (BioRad).
R Overlay R overlays were conducted as described, using 32 P-labeled recombinant murine or human RIIa (Hausken et al., 1998) or recombinant bovine or human RIa (A98S) (Carlson et al., 2006) . Briefly, the membrane was blocked in blotto (5% [w/v] nonfat dry milk plus 0.1% bovine serum albumin in Tris-buffered saline [TBS] ). Purified recombinant R (4 mg) was radiolabeled with purified catalytic subunit (C) of PKA (0.02 mg/ml) and [g-32 P] ATP (1.4 mCi ml -1 ) in 50 mM MOPS, 50 mM NaCl, 2 mM MgCl 2 , and 1 mM DTT (pH 6.8) and separated from free 32 P-ATP by gel filtration (G-50 Sepharose). The membrane was washed in TBS with 0.1% Tween-20 (TBST) and signal detected by autoradiography. Because affinities of AKAP-IS and derivates were high for RII and low for RI, exposure times for peptide arrays overlayed with RII were 5-10 min, whereas exposure times for arrays overlaid with RI were 3-12 hr.
Cell Cultures and Transient Transfections HEK293 cells were maintained in DMEM supplemented with 100 mg/ ml streptomycin, 100 U/ml penicillin, and 10% (v/v) fetal calf serum in a humidified atmosphere of 5% CO 2 and split by trypsination at less than 80% confluence. HEK293 cells at 50%-80% confluency were transfected with 10 mg of plasmid DNA (GFP, GFP-SuperAKAP-IS, GFP-AKAP-IS, and GFP-scrambled AKAP-IS) per 56.7 cm 2 culture dishes by using the CaCl 2 method. Cells were lysed after 30 hr in lysis buffer (20 mM HEPES [pH 7.5], 150 mM NaCl, 1 mM EDTA, and 1% Triton X-100) with protease inhibitors (Complete Mini, EDTAfree tablets, Roche).
Immunoblot Analysis
Cell lysates were analyzed on 15% PAGE and blotted onto PVDF membranes. The filters were blocked in 5% nonfat dry milk in TBST for 30 min at RT, incubated 1 hr at RT or overnight at 4 C with anti-GFP monoclonal antibody (Clontech) at a 1 mg ml 21 dilution for immunoblotting, washed four times for 5 min in TBST, and incubated with HRP-conjugated anti-mouse as secondary antibodies at a 1:5000 dilution (Jackson Immunoresearch). Blots were developed by using Supersignal West Pico substrate (Pierce).
Peptide Synthesis
SuperAKAP-IS, scrambled SuperAKAP-IS (scSuperAKAP-IS: QDVE IHVKAAYYQQIAI), Arg 11 -AKAP-IS, Arg 11 -SuperAKAP-IS, Arg 11 -Ht31 (Arg 11 -LIEEAASRIVDAVIEQV), and RIAD-Arg 11 (LEQYANQLAD QIIKEATE-Arg 11 ) were synthesized and purified to >80% purity (SynPep, or in house at the Biotechnology Centre). The peptide concentrations used were exactly determined by amino acid analysis using Applied Biosystems Analyzer 421. AKAP-IS was synthesized at high purity (>90%) for crystallization (Jacky Metcalfe, Institute of Cancer Research, Sutton).
Immunofluorescence
Immunofluorescence was performed on human peripheral blood T cells purified as described (Aandahl et al., 1998) . Arginine-coupled peptides were added to the cell culture and incubated for 1 hr. Cells were attached to polylysin-coated coverslips, washed in PBS, fixed with 3% paraformaldehyde, and permeabilized using 0.1% Triton X-100. Proteins were blocked in 2% BSA/PBST prior to antibody labeling. Mouse primary antibody against RIa (clone 4D7 [Skalhegg et al., 1994; Tasken et al., 1993] ), RIIa (BD Transduction Laboratories), and Alexa 488 anti-mouse IgG secondary antibody (Molecular Probes, Invitrogen) were used at 1:200 and 1:500 dilution, respectively, in BSA/PBST and incubated for 30 min. Cells were examined using a Zeiss LSM 510 META confocal fluorescence microscope.
Electrophysiology
Whole-cell recordings were made with an Axopatch200B amplifier (Axon Instruments). Patch pipettes (2-4 MU) contained (in mM) 140 cesium methanesulfonate, 5 adenosine triphosphate, 5 MgCl 2 , 0.2 CaCl 2 , 1 BAPTA (1,2-bis[2-aminophenoxy]ethane-N,N,N',N 0 -tetraacetate), and 10 HEPES (pH 7.4). Extracellular solution contained (in mM) 150 NaCl, 5 KCl, 1.8 CaCl 2 , 10 glucose, 0.1 cyclothiazide, and 10 HEPES (pH 7.4). Solution exchanges were accomplished through a two-barrel pipe controlled by a solution stimulus delivery device, SF-77B (Warner Instruments,). The GluR1 (AMPA channel subunit) receptor currents were evoked by a 500 ms application of 1 mM glutamate at 30 s intervals. Data were acquired and analyzed by using PCLAMP software (Axon Instruments). Currents were digitized at 5 kHz and filtered at 1 kHz.
Supplemental Data
Supplemental Data include one table and can be found with this article online at http://www.molecule.org/cgi/content/full/24/3/ 383/DC1/.
